[{"AccountsPayableCurrent_0_Q1_USD":2855000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_1_Q1_USD":369000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":61532000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":369000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":159000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":924000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":85000.0,"EquityMethodInvestments_0_Q1_USD":623000.0,"OtherReceivablesNetCurrent_0_Q1_USD":32000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q1_USD":-0.09,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q1_USD":-0.09,"AllocatedShareBasedCompensationExpense_1_Q1_USD":924000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":924000.0,"ContractWithCustomerAssetNetCurrent_0_Q1_USD":150000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":4926000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":9302000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":43294000.0,"OtherAssetsCurrent_0_Q1_USD":3324000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":-249000.0,"PrepaidTaxes_0_Q1_USD":46000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-336000.0,"StockRepurchasedDuringPeriodValue_1_Q1_USD":46000.0,"SellingAndMarketingExpense_1_Q1_USD":1597000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":12000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-1673000.0,"TaxesPayableCurrent_0_Q1_USD":56000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":61322000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-339000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":18028000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":444000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":130000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q1_USD":0.0,"OtherNoncashIncomeExpense_1_Q1_USD":42000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q1_USD":-3000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0625,"OperatingLeaseRightOfUseAsset_0_Q1_USD":2525000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":2143000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":431000.0,"OperatingLeaseLiability_0_Q1_USD":2574000.0,"OperatingLeaseCost_1_Q1_USD":149000.0,"NumberOfReportableSegments_1_Q1_Segment":1.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":476000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":433000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":591000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":597000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":567000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":330000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":3050000.0,"InvestmentIncomeAmortizationOfPremium_1_Q1_USD":105000.0,"IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_1_Q1_USD":34000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":268000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_0_Q1_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-3000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q1_USD":0.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":242000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-2663000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":7992000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-2295000.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":121000.0,"ProfitLoss_1_Q1_USD":-1956000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":796000.0,"NetIncomeLoss_1_Q1_USD":-1956000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":1366000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-3862000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-164000.0,"LiabilitiesCurrent_0_Q1_USD":5810000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":89325000.0,"Liabilities_0_Q1_USD":7953000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-104000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":1907000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":34000.0,"GrossProfit_1_Q1_USD":3696000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":2035000.0,"EquityMethodInvestmentOwnershipPercentage_0_Q1_pure":0.3,"Depreciation_1_Q1_USD":569000.0,"CostOfRevenue_1_Q1_USD":4057000.0,"CommonStockValue_0_Q1_USD":2000.0,"CommonStockSharesOutstanding_0_Q1_shares":21672000.0,"CommonStockSharesIssued_0_Q1_shares":21672000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":9302000.0,"AssetsCurrent_0_Q1_USD":37025000.0,"Assets_0_Q1_USD":89325000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-193000.0,"AccountsReceivableNetCurrent_0_Q1_USD":6371000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":5698000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":3943000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-65385000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":2024000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":146948000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":21566000.0,"OtherAssetsNoncurrent_0_Q1_USD":160000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":43000.0,"PrepaidExpenseCurrent_0_Q1_USD":1211000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":14257000.0,"InterestAndOtherIncome_1_Q1_USD":241000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":-0.02,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":8559000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":21566000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":12000.0,"ShareBasedCompensation_1_Q1_USD":924000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":1978000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":1000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":46000.0,"OperatingIncomeLoss_1_Q1_USD":-1914000.0,"OperatingExpenses_1_Q1_USD":5610000.0,"CommonStockSharesAuthorized_0_Q1_shares":50000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":862000.0,"StockholdersEquity_0_Q1_USD":81372000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":7753000.0,"Ticker":"FLGT","CIK":"1674930","name":"FULGENT GENETICS, INC.","OfficialName":"Fulgent Genetics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1793543393.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20200506"}]